BACKGROUND: Vascular endothelial E-selectin expression is induced by proinflammatory cytokines and contributes to accumulation of leucocytes in tissues. AIMS: To investigate the role of E-selectin in inflammatory bowel disease (IBD). METHODS: E-selectin expression was assessed in patients with ulcerative colitis and Crohn's disease by measuring the concentration of circulating soluble E-selectin (sE-selectin) using ELISA, by immunohistochemistry of colonic biopsy specimens, and by abdominal immunoscintigraphy after injecting radiolabelled F(ab')2 fragment of a monoclonal anti-E-selectin antibody. The value of scintigraphy using anti-E-selectin was judged by a prospective comparative study of autologous leucocyte scanning and E-selectin antibody scanning in 17 patients with IBD. RESULTS: Circulating sE-selectin was elevated in patients with clinically active disease. Tissue expression of E-selectin was enhanced in patients with active inflammation, with weak or absent expression in inactive disease and healthy controls. In-111 labelled anti-E-selectin scintiscans were compared with Tc-99m labelled leucocyte scans performed 24 hours earlier. Twelve patients had areas of active inflammation on leucocyte scan while 11 patients had positive E-selectin scans. The results of the two scans were concordant in 14 patients, with those positive for both (10/17) showing similar disease localisation and extent. CONCLUSIONS: Tissue E-selectin and circulating sE-selectin are increased during active inflammatory bowel disease. Anti-E-selectin imaging with radiolabelled monoclonal antibody identified areas of inflammation in Crohn's disease and ulcerative colitis. The technique should prove useful clinically for identifying the site and extent of disease.
BACKGROUND: Vascular endothelial E-selectin expression is induced by proinflammatory cytokines and contributes to accumulation of leucocytes in tissues. AIMS: To investigate the role of E-selectin in inflammatory bowel disease (IBD). METHODS:E-selectin expression was assessed in patients with ulcerative colitis and Crohn's disease by measuring the concentration of circulating soluble E-selectin (sE-selectin) using ELISA, by immunohistochemistry of colonic biopsy specimens, and by abdominal immunoscintigraphy after injecting radiolabelled F(ab')2 fragment of a monoclonal anti-E-selectin antibody. The value of scintigraphy using anti-E-selectin was judged by a prospective comparative study of autologous leucocyte scanning and E-selectin antibody scanning in 17 patients with IBD. RESULTS: Circulating sE-selectin was elevated in patients with clinically active disease. Tissue expression of E-selectin was enhanced in patients with active inflammation, with weak or absent expression in inactive disease and healthy controls. In-111 labelled anti-E-selectin scintiscans were compared with Tc-99m labelled leucocyte scans performed 24 hours earlier. Twelve patients had areas of active inflammation on leucocyte scan while 11 patients had positive E-selectin scans. The results of the two scans were concordant in 14 patients, with those positive for both (10/17) showing similar disease localisation and extent. CONCLUSIONS: Tissue E-selectin and circulating sE-selectin are increased during active inflammatory bowel disease. Anti-E-selectin imaging with radiolabelled monoclonal antibody identified areas of inflammation in Crohn's disease and ulcerative colitis. The technique should prove useful clinically for identifying the site and extent of disease.
Authors: S M Wellicome; M H Thornhill; C Pitzalis; D S Thomas; J S Lanchbury; G S Panayi; D O Haskard Journal: J Immunol Date: 1990-04-01 Impact factor: 5.422
Authors: M E Roddie; A M Peters; H J Danpure; S Osman; B L Henderson; J P Lavender; M J Carroll; R D Neirinckx; J D Kelly Journal: Radiology Date: 1988-03 Impact factor: 11.105
Authors: R H Rubin; A J Fischman; R J Callahan; B A Khaw; F Keech; M Ahmad; R Wilkinson; H W Strauss Journal: N Engl J Med Date: 1989-10-05 Impact factor: 91.245
Authors: A J Fischman; R H Rubin; B A Khaw; R J Callahan; R Wilkinson; F Keech; M Nedelman; S Dragotakes; P B Kramer; G M LaMuraglia Journal: Semin Nucl Med Date: 1988-10 Impact factor: 4.446
Authors: Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas; Ioannis E Koutroubakis Journal: World J Gastroenterol Date: 2009-06-14 Impact factor: 5.742
Authors: Huaijun Wang; Stephen A Felt; Ismayil Guracar; Valentina Taviani; Jianhua Zhou; Rosa Maria Silveira Sigrist; Huiping Zhang; Joy Liau; José G Vilches-Moure; Lu Tian; Yamil Saenz; Thierry Bettinger; Brian A Hargreaves; Amelie M Lutz; Jürgen K Willmann Journal: Eur Radiol Date: 2017-11-23 Impact factor: 5.315
Authors: Amanda C Freise; Kirstin A Zettlitz; Felix B Salazar; Richard Tavaré; Wen-Ting K Tsai; Arion F Chatziioannou; Nora Rozengurt; Jonathan Braun; Anna M Wu Journal: J Nucl Med Date: 2018-01-11 Impact factor: 10.057
Authors: V von Baehr; W D Döcke; M Plauth; C Liebenthal; S Küpferling; H Lochs; R Baumgarten; H D Volk Journal: Gut Date: 2000-08 Impact factor: 23.059
Authors: Huaijun Wang; Steven Machtaler; Thierry Bettinger; Amelie M Lutz; Richard Luong; Philippe Bussat; Sanjiv S Gambhir; François Tranquart; Lu Tian; Jürgen K Willmann Journal: Radiology Date: 2013-01-31 Impact factor: 11.105